AIRG vs GSK · rev $25.2M vs P/E 13, $103.31B cap
Airgain Inc (AIRG) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Airgain Inc (AIRG) is a communication equipment company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported AIRG revenue for 2026-06-30 was $25.2M. Net income was -$3.6M. AIRG currently screens at market cap $49.3M.
GSK does not have a complete income-statement cache yet.
AIRG currently screens at market cap $49.3M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the AIRG and GSK stock pages for the full models.
Not investment advice.